Cabenuva

cabotegravir and rilpivirine (co-packaged)

Approval

ApplicationNDA 212888
Approval dateJan 21, 2021
Approval year2021
SponsorViiv Hlthcare

FDA-approved use

To treat HIV

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Cabenuva: